Zhejiang Qianjiang Biochemical (SHA:600796) will transfer about 224.9 million yuan in net assets to wholly-owned subsidiary Qichao Biotech, in a no-consideration transfer.
The transfer includes assets, liabilities, and employee relationships from the Biochemical Branch production base as part of a relocation project.
The move aims to optimize asset structure and operational efficiency without changing the consolidated reporting scope.
Shares of the biochemical company closed 2% lower Thursday.
CSE Global's (SGX:544) revenue surged 29% during the first quarter of the year to SG$265.2 million from SG$205.5 million a year earlier, according to a Thursday filing with the Singapore Exchange.Order intake zoomed 75% year over year to SG$271.2 million from SG$155.3 million, backed by strong growth in the electrification segment.
Caplin Point Laboratories (NSE:CAPLIPOINT, BOM:524742) consolidated attributable profit rose to 1.70 billion Indian rupees in the fiscal fourth quarter ended March 31, from 1.43 billion rupees a year ago.Earnings per share came in at 22.31 rupees from 18.69 rupees a year earlier, the pharmaceutical company said in a filing to the Indian stock exchanges on Thursday.Revenue from operations in fiscal Q4 also increased to 6.00 billion rupees from 5.02 billion rupees a year ago.The company's board declared an interim dividend of 4 rupees per equity share of face value of 2 rupees each for the financial year ended March 31.Caplin Point's shares were up over 10% in recent trade.
Prism Johnson's (NSE:PRSMJOHNSN, BOM:500338) consolidated attributable profit plunged to 64.3 million Indian rupees in the fiscal fourth quarter ended March 31, from 1.29 billion rupees a year ago.Earnings per share contracted to 0.13 rupees from 2.57 rupees a year earlier, the business materials manufacturer said in a filing to the Indian stock exchanges on Thursday.Revenue from operations in fiscal Q4 increased to 20.9 billion rupees from 19.5 billion rupees a year ago.The company's shares were up nearly 1% in recent trade.